India, May 25 -- Recent demographic data from the 2024 Census ACS 5 Year Survey reveals significant variations in the number of American Indian and Alaska Native individuals living with disabilities a... Read More
India, May 25 -- Recent demographic findings reveal significant variations in the number of individuals living with disabilities across different racial groups in the United States. This data, derived... Read More
India, May 25 -- The 2024 Census ACS 5-Year Survey provides a detailed statistical breakdown of the male population with disabilities across the United States. Concentration in Populous States Califo... Read More
India, May 25 -- New demographic data highlights significant variations in the female population living with disabilities across different regions of the United States. These findings from the 2024 Ce... Read More
Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061674) titled 'Evaluation of a Class for Healthcare Students on Medical Communication with ... Read More
Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061664) titled 'ENtire ABLation rEgistry of Osaka CardioVascular Conference: ENABLE-OCVC' on... Read More
Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061663) titled 'Construction of a case database for lung cancer surgery cases' on May 25. S... Read More
Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061595) titled 'Molecular, Cellular, and Spatial Analysis of Granulomas in Crohn's Disease' ... Read More
Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More
Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More